Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results.
Blood (2012)
  • Brian G. Till, Fred Hutchinson Cancer Research Center
  • Michael C. Jensen, Seattle Children's Research Institute
  • Jinjuan Wang, Fred Hutchinson Cancer Research Center
  • Xiaojun Qian, Fred Hutchinson Cancer Research Center
  • Ajay K. Gopal, Fred Hutchinson Cancer Research Center
  • David G. Maloney, Fred Hutchinson Cancer Research Center
  • Catherine G. Lindgren, Fred Hutchinson Cancer Research Center
  • Yukang Lin, Fred Hutchinson Cancer Research Center
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • Lihua E. Budde, Fred Hutchinson Cancer Research Center
  • Andrew Raubitschek, City of Hope National Medical Center
  • Stephen J. Forman, City of Hope National Medical Center
  • Philip D. Greenberg, Fred Hutchinson Cancer Research Center
  • Stanley R. Riddell, Fred Hutchinson Cancer Research Center
  • Oliver W. Press, Fred Hutchinson Cancer Research Center
Link
Disciplines
Publication Date
April 26, 2012
DOI
10.1182/blood-2011-10-387969
Citation Information
Brian G. Till, Michael C. Jensen, Jinjuan Wang, Xiaojun Qian, et al.. "CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results." Blood Vol. 119 Iss. 17 (2012) p. 3940 - 3950
Available at: http://works.bepress.com/john-pagel/166/